Last reviewed · How we verify

NCT07455552

Comparison of Telemedicine-based and Home-based Inspiratory Muscle Training After Lung Resection in High-risk Patients

Completed NA Last updated 6 March 2026
What this trial tests

NA trial testing 1:1 telemedicine-based inspiratory muscle training in Pulmonary Disease in 58 participants. Completed in 29 December 2025.

Timeline
13 August 2024
Primary endpoint
29 December 2025
29 December 2025

Quick facts

Lead sponsorPusan National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment58
Start date13 August 2024
Primary completion29 December 2025
Estimated completion29 December 2025
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Pusan National University Hospital

Who can join

65 and older, any sex, with Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effectiveness of remote inspiratory muscle training (IMT) after surgery in high-risk patients undergoing pulmonary lobectomy, using a randomized controlled trial design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pulmonary Disease

Currently open trials in the same condition.

Other Pusan National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07455552.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing